CD200 and marginal zone lymphoma: Further, CD200 expression (MFIR ≥ 18.0); was seen in all cases of CLL and in 20/53 (37.7%) cases from non-CLL group; including 5 of 8 HCL cases and 12 of 17 MZL but non from MCL group.